Intended Purpose; Indications; Contraindications - L&R Suprasorb CNP P3 Mode D'emploi

1.4 Intended purpose

The Suprasorb CNP P3 therapy unit is designed to drain exudate by suction during
®
Suprasorb CNP (Controlled Negative Pressure) therapy. It is intended for patients likely
®
to benefit from negative pressure wound care.

1.4.1 Indications

The Suprasorb CNP P3 therapy unit can be used on both uninfected and contaminated,
®
colonised, critically colonised or infected wounds with light, moderate or heavy amounts of
exudate and which are superficial or deep.
Possible areas of application:
• lower leg ulcers (venous, arterial, mixed)
• decubitus
• diabetic foot lesions
• post-traumatic and post-operative wounds
• initially infected wounds following surgical debridement
• soft tissue injuries (lacerated contusions, degloving)
• injuries exposing the underlying bone or bradytrophic tissue
• wounds following splitting of a compartment on an extremity
• conditions following skin grafts (e.g., mesh graft, up to reliable integration of the graft on day 5/6)
• sternal wound infections following surgical debridement
• open abdominal procedures including treatment of fistulae (in combination with
Suprasorb CNP Drainage Film only)
®
• treatment of 1st and 2nd degree burns

1.4.2 Contraindications

Suprasorb CNP P3 is contraindicated for the following applications:
®
• exposed vessels likely to be compromised by negative pressure; the same applies for
vascular anastomoses
• coagulation disorders (risk of haemorrhaging)
• slight to heavy acute bleeding in the wound area following injury/surgical debridement
• necrotic tissue
• unexplored fistulas
• untreated osteomyelitis
• malignant wounds
• exposed organs without suitable organ protection
• dry wound conditions
• 3rd degree burns
• use on the sternum
(with the exception of sternal wound infections following surgical debridement)